BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24494686)

  • 1. No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids.
    Hu SS; Ho YC; Chiou LC
    Eur J Neurosci; 2014 Feb; 39(3):467-84. PubMed ID: 24494686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the cannabinoid system for pain relief?
    Chiou LC; Hu SS; Ho YC
    Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia.
    Gregg LC; Jung KM; Spradley JM; Nyilas R; Suplita RL; Zimmer A; Watanabe M; Mackie K; Katona I; Piomelli D; Hohmann AG
    J Neurosci; 2012 Jul; 32(28):9457-68. PubMed ID: 22787031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation.
    Bouchet CA; McPherson KB; Coutens B; Janowsky A; Ingram SL
    J Neurosci; 2023 Jul; 43(30):5458-5467. PubMed ID: 37414560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide S-initiated sequential cascade mediated by OX
    Lee MT; Chiu YT; Chiu YC; Hor CC; Lee HJ; Guerrini R; Calo G; Chiou LC
    J Biomed Sci; 2020 Jan; 27(1):7. PubMed ID: 31915019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.
    Galve-Roperh I; Chiurchiù V; Díaz-Alonso J; Bari M; Guzmán M; Maccarrone M
    Prog Lipid Res; 2013 Oct; 52(4):633-50. PubMed ID: 24076098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids and Their Pharmacological Actions.
    Pertwee RG
    Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.
    Loría F; Petrosino S; Mestre L; Spagnolo A; Correa F; Hernangómez M; Guaza C; Di Marzo V; Docagne F
    Eur J Neurosci; 2008 Aug; 28(4):633-41. PubMed ID: 18657182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of the endocannabinoid system in the sleep-wake cycle modulation.
    Murillo-Rodriguez E; Poot-Ake A; Arias-Carrion O; Pacheco-Pantoja E; Fuente-Ortegon Ade L; Arankowsky-Sandoval G
    Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):189-96. PubMed ID: 21919868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endogenous cannabinoid system and its role in nociceptive behavior.
    Cravatt BF; Lichtman AH
    J Neurobiol; 2004 Oct; 61(1):149-60. PubMed ID: 15362158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases.
    Páez JA; Campillo NE
    Curr Med Chem; 2019; 26(18):3300-3340. PubMed ID: 29484980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of cannabinoid receptor ligands: current status.
    Singh J; Budhiraja S
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid mechanisms of pain modulation.
    Hohmann AG; Suplita RL
    AAPS J; 2006 Nov; 8(4):E693-708. PubMed ID: 17233533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anandamide in primary sensory neurons: too much of a good thing?
    Sousa-Valente J; Varga A; Ananthan K; Khajuria A; Nagy I
    Eur J Neurosci; 2014 Feb; 39(3):409-18. PubMed ID: 24494681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation.
    Alvarez-Jaimes LJ; Palmer JA
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1644-59. PubMed ID: 21466449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids and the Digestive Tract and Bladder in Health and Disease.
    Izzo AA; Muccioli GG; Ruggieri MR; Schicho R
    Handb Exp Pharmacol; 2015; 231():423-47. PubMed ID: 26408170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.